Notable Analyst Upgrades and Downgrades for Week of November 13, 2017



Upgrades:


Automatic Data Processing (NYSE:ADP) was upgraded by investment analysts at Morgan Stanley from an “underweight” rating to an “equal” rating in a research report issued to clients and investors on Tuesday. A number of other brokerages have also issued reports on ADP. BidaskClub raised shares of Automatic Data Processing from a “hold” rating to a “buy” rating in a report on Thursday, September 28th. BMO Capital Markets cut their price objective on shares of Automatic Data Processing from $122.00 to $114.00 and set an “outperform” rating for the company in a report on Friday, November 3rd. Bank of America Corporation increased their price objective on shares of Automatic Data Processing from $111.00 to $114.00 and gave the company a “neutral” rating in a report on Friday, October 13th. Barclays PLC reaffirmed an “equal weight” rating and set a $105.00 price objective on shares of Automatic Data Processing in a report on Tuesday, August 15th. Read more …

Air Products and Chemicals, Inc. (NYSE:APD) was upgraded by investment analysts at HSBC Holdings plc from a “hold” rating to a “buy” rating in a research note issued on Monday, The Fly reports. A number of other brokerages also recently commented on APD. Deutsche Bank AG boosted their target price on shares of Air Products and Chemicals from $160.00 to $168.00 and gave the stock a “hold” rating in a report on Wednesday, August 2nd. Susquehanna Bancshares Inc boosted their target price on shares of Air Products and Chemicals and gave the stock a “positive” rating in a report on Tuesday, November 7th. Jefferies Group LLC reiterated a “hold” rating and issued a $155.00 target price on shares of Air Products and Chemicals in a report on Thursday, September 28th. SunTrust Banks, Inc. reiterated a “buy” rating and issued a $175.00 target price on shares of Air Products and Chemicals in a report on Friday, October 27th. Read more …

Coca-Cola Company (The) (NYSE:KO) was upgraded by investment analysts at Wells Fargo & Company from a “market perform” rating to an “outperform” rating in a note issued to investors on Tuesday, The Fly reports. Several other equities research analysts have also recently weighed in on the company. Vetr upgraded Coca-Cola Company (The) from a “sell” rating to a “strong-buy” rating in a research note on Tuesday, September 12th. Royal Bank Of Canada set a $49.00 target price on Coca-Cola Company (The) and gave the company a “buy” rating in a report on Sunday. UBS AG boosted their target price on Coca-Cola Company (The) from $49.00 to $51.00 and gave the company a “buy” rating in a report on Thursday, July 27th. Read more …

Sanofi (NYSE:SNY) was upgraded by equities research analysts at Barclays PLC from an “underweight” rating to an “equal weight” rating in a research report issued on Wednesday. A number of other research firms also recently weighed in on SNY. Zacks Investment Research downgraded Sanofi from a “hold” rating to a “strong sell” rating in a research report on Friday, October 6th. raised Sanofi from a “reduce” rating to a “hold” rating in a research report on Wednesday, August 30th. Argus reissued a “buy” rating and set a $55.00 target price on shares of Sanofi in a research report on Friday, September 1st. J P Morgan Chase & Co reissued a “neutral” rating on shares of Sanofi in a research report on Friday, September 15th. Finally, BidaskClub raised Sanofi from a “sell” rating to a “hold” rating in a research report on Saturday, August 5th. Read more ...

Occidental Petroleum Corporation (NYSE:OXY) was upgraded by stock analysts at The Goldman Sachs Group, Inc. from a “neutral” rating to a “buy” rating in a report released on Friday. A number of other research analysts have also weighed in on OXY. Morgan Stanley raised their price target on shares of Occidental Petroleum Corporation from $62.00 to $66.00 and gave the company an “equal weight” rating in a research note on Wednesday, October 18th. Jefferies Group LLC set a $58.00 price target on shares of Occidental Petroleum Corporation and gave the company a “hold” rating in a research report on Tuesday, August 29th. Read more …


Downgrades:


Argus lowered shares of Gilead Sciences, Inc. (NASDAQ:GILD) from a buy rating to a hold rating in a research report released on Monday morning. Argus currently has $73.77 target price on the biopharmaceutical company’s stock, up from their previous target price of $73.25. Several other equities research analysts have also recently issued reports on the stock. Mizuho lifted their price objective on shares of Gilead Sciences from $77.00 to $83.00 and gave the company a buy rating in a research report on Wednesday, November 8th. Maxim Group reiterated a hold rating on shares of Gilead Sciences in a research report on Friday, October 27th. BMO Capital Markets reduced their price objective on shares of Gilead Sciences from $89.00 to $83.00 and set an outperform rating on the stock in a research report on Friday, October 27th. J P Morgan Chase & Co set a $85.00 price objective on shares of Gilead Sciences and gave the company a buy rating in a research report on Wednesday, October 25th. Read more …

J P Morgan Chase & Co downgraded shares of Rio Tinto PLC (NYSE:RIO) from an overweight rating to a neutral rating in a research report report published on Monday morning, MarketBeat Ratings reports. Other equities research analysts have also issued research reports about the stock. Societe Generale upgraded shares of Rio Tinto PLC from a hold rating to a buy rating in a research note on Wednesday, November 8th. Citigroup Inc. downgraded shares of Rio Tinto PLC from a buy rating to a neutral rating in a research note on Tuesday, October 17th. Cowen and Company set a $47.00 price target on shares of Rio Tinto PLC and gave the company a hold rating in a report on Monday, October 16th. Clarkson Capital lowered shares of Rio Tinto PLC from a buy rating to a neutral rating in a research report on Monday, October 16th. Read more …

Schlumberger N.V. (NYSE:SLB) was downgraded by investment analysts at Goldman Sachs Group, Inc. (The) from a “conviction-buy” rating to a “buy” rating in a report released on Monday. They currently have a $75.00 price target on the oil and gas company’s stock. Goldman Sachs Group, Inc. (The)’s price target indicates a potential upside of 19.46% from the stock’s current price. SLB has been the topic of several other reports. Zacks Investment Research lowered Schlumberger N.V. from a “hold” rating to a “sell” rating in a report on Wednesday, November 1st. FBR & Co reissued a “buy” rating on shares of Schlumberger N.V. in a report on Friday, October 20th. Piper Jaffray Companies set a $74.00 target price on Schlumberger N.V. and gave the stock a “buy” rating in a report on Saturday, October 21st. Sanford C. Bernstein reissued an “outperform” rating and set a $80.00 target price on shares of Schlumberger N.V. in a report on Wednesday, September 6th. Read more …

J P Morgan Chase & Co downgraded shares of Teva Pharmaceutical Industries Limited (NYSE:TEVA) from a neutral rating to an underweight rating in a report published on Monday morning. The firm currently has $11.00 price objective on the stock, down from their previous price objective of $11.48. A number of other research firms have also recently weighed in on TEVA. Jefferies Group LLC restated a hold rating on shares of Teva Pharmaceutical Industries Limited in a report on Tuesday, July 25th. Vetr upgraded Teva Pharmaceutical Industries Limited from a hold rating to a buy rating and set a $34.17 price target on the stock in a report on Monday, July 24th. Zacks Investment Research upgraded Teva Pharmaceutical Industries Limited from a sell rating to a hold rating in a report on Monday, July 17th. Royal Bank Of Canada restated an outperform rating and issued a $37.00 price target (down previously from $38.00) on shares of Teva Pharmaceutical Industries Limited in a report on Monday, July 17th. Read more …

Phillips 66 (NYSE:PSX) was downgraded by stock analysts at Barclays PLC from an “equal weight” rating to an “underweight” rating in a note issued to investors on Tuesday. They presently have a $100.00 price target on the oil and gas company’s stock, up from their prior price target of $95.00. Barclays PLC’s price target indicates a potential upside of 7.49% from the company’s previous close. A number of other analysts have also recently weighed in on PSX. Scotiabank set a $86.00 price target on Phillips 66 and gave the company a “hold” rating in a research report on Tuesday, August 1st. BidaskClub cut Phillips 66 from a “hold” rating to a “sell” rating in a research report on Friday, August 18th. Jefferies Group LLC reiterated a “hold” rating and issued a $78.00 price target on shares of Phillips 66 in a research report on Tuesday, September 5th. Piper Jaffray Companies reiterated a “buy” rating and issued a $98.00 price target on shares of Phillips 66 in a research report on Tuesday, September 26th. Read more ...

Cardinal Health, Inc. (NYSE:CAH) was downgraded by stock analysts at Argus from a “buy” rating to a “hold” rating in a note issued to investors on Wednesday. Several other equities analysts have also recently commented on CAH. Jefferies Group LLC lowered their price target on shares of Cardinal Health from $77.00 to $67.00 and set a “hold” rating on the stock in a report on Tuesday, November 7th. Zacks Investment Research upgraded shares of Cardinal Health from a “sell” rating to a “hold” rating in a report on Wednesday, November 8th. BidaskClub cut shares of Cardinal Health from a “hold” rating to a “sell” rating in a report on Friday, August 4th. Credit Suisse Group decreased their price objective on shares of Cardinal Health from $87.00 to $81.00 and set an “outperform” rating for the company in a report on Thursday, August 3rd. Read more ...

Williams-Sonoma, Inc. (NYSE:WSM) was downgraded by research analysts at J P Morgan Chase & Co from an “overweight” rating to an “underweight” rating in a research note issued to investors on Friday. A number of other research firms have also issued reports on WSM. Robert W. Baird set a $48.00 price target on Williams-Sonoma and gave the company a “hold” rating in a research report on Tuesday, October 31st. Zacks Investment Research lowered Williams-Sonoma from a “buy” rating to a “sell” rating in a research report on Wednesday. TheStreet raised Williams-Sonoma from a “c+” rating to a “b-” rating in a research report on Monday, October 9th. Credit Suisse Group lowered Williams-Sonoma from a “neutral” rating to an “underperform” rating and set a $44.00 target price on the stock. in a research report on Thursday, October 12th. Read more …


In case you interested of stock analysis of other bloggers, click on link below:


Analysis Collection


Comments